Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction me...
Saved in:
Published in | Blood Vol. 116; no. 22; pp. e111 - e117 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
25.11.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials. |
---|---|
AbstractList | Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials. Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials.Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials. |
Author | Zoi, Katerina Colomer, Dolors White, Helen E. Kairisto, Veli Dvorakova, Dana Press, Richard D. Goh, Hyun-Gyung Kamel-Reid, Suzanne Cross, Nicholas C.P. Langabeer, Stephen Wang, Lihui El Housni, Hakim Saglio, Giuseppe Matejtschuk, Paul Kim, Dong-Wook Rigsby, Peter Ehrencrona, Hans Gabert, Jean Romeo, Giuliana Ma, Edmond S.K. Lynn Wang, Y. Lin, Feng Jones, Dan Müller, Martin C. Goldman, John M. Beaufils, Nathalie Beillard, Emmanuel Hochhaus, Andreas Metcalfe, Paul Branford, Susan Hughes, Timothy |
Author_xml | – sequence: 1 givenname: Helen E. surname: White fullname: White, Helen E. organization: National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom – sequence: 2 givenname: Paul surname: Matejtschuk fullname: Matejtschuk, Paul organization: National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, United Kingdom – sequence: 3 givenname: Peter surname: Rigsby fullname: Rigsby, Peter organization: National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, United Kingdom – sequence: 4 givenname: Jean surname: Gabert fullname: Gabert, Jean organization: Biochemistry and Molecular Laboratory, Hopital Nord–Assistance Publique–Hôpitaux de Marseille, Marseille, France – sequence: 5 givenname: Feng surname: Lin fullname: Lin, Feng organization: National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom – sequence: 6 givenname: Y. surname: Lynn Wang fullname: Lynn Wang, Y. organization: Molecular Hematopathology Laboratory, Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY – sequence: 7 givenname: Susan surname: Branford fullname: Branford, Susan organization: Department of Molecular Pathology, SA Pathology and the University of Adelaide, Adelaide, Australia – sequence: 8 givenname: Martin C. surname: Müller fullname: Müller, Martin C. organization: III Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany – sequence: 9 givenname: Nathalie surname: Beaufils fullname: Beaufils, Nathalie organization: Biochemistry and Molecular Laboratory, Hopital Nord–Assistance Publique–Hôpitaux de Marseille, Marseille, France – sequence: 10 givenname: Emmanuel surname: Beillard fullname: Beillard, Emmanuel organization: MolecularMD, Portland, OR – sequence: 11 givenname: Dolors surname: Colomer fullname: Colomer, Dolors organization: Unitat d'hematopatologia, Hospital Clinic, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain – sequence: 12 givenname: Dana surname: Dvorakova fullname: Dvorakova, Dana organization: University Hospital Brno and Masaryk University, Center of Molecular Biology and Gene Therapy, Brno, Czech Republic – sequence: 13 givenname: Hans surname: Ehrencrona fullname: Ehrencrona, Hans organization: Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden – sequence: 14 givenname: Hyun-Gyung surname: Goh fullname: Goh, Hyun-Gyung organization: Molecular Genetics Research Institute, The Catholic University of Korea, Seoul, Republic of Korea – sequence: 15 givenname: Hakim surname: El Housni fullname: El Housni, Hakim organization: Medical Genetics Department, Erasme Hospital, Brussels, Belgium – sequence: 16 givenname: Dan surname: Jones fullname: Jones, Dan organization: Molecular Diagnostics Laboratory, The University of Texas M. D. Anderson Cancer Center, Houston, TX – sequence: 17 givenname: Veli surname: Kairisto fullname: Kairisto, Veli organization: Turku University Hospital Laboratories, TYKSLAB, Turku, Finland – sequence: 18 givenname: Suzanne surname: Kamel-Reid fullname: Kamel-Reid, Suzanne organization: Department of Pathology, The University Health Network, Toronto, ON – sequence: 19 givenname: Dong-Wook surname: Kim fullname: Kim, Dong-Wook organization: Molecular Genetics Research Institute, The Catholic University of Korea, Seoul, Republic of Korea – sequence: 20 givenname: Stephen surname: Langabeer fullname: Langabeer, Stephen organization: Cancer Molecular Diagnostics, Central Pathology Laboratory, St James's Hospital, Dublin, Ireland – sequence: 21 givenname: Edmond S.K. surname: Ma fullname: Ma, Edmond S.K. organization: Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong – sequence: 22 givenname: Richard D. surname: Press fullname: Press, Richard D. organization: Department of Pathology, Oregon Health and Science University, Portland, OR – sequence: 23 givenname: Giuliana surname: Romeo fullname: Romeo, Giuliana organization: Molecular Haematology Laboratory, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Australia – sequence: 24 givenname: Lihui surname: Wang fullname: Wang, Lihui organization: Department of Haematology, Royal Liverpool University Hospital, Liverpool, United Kingdom – sequence: 25 givenname: Katerina surname: Zoi fullname: Zoi, Katerina organization: Haematology Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece – sequence: 26 givenname: Timothy surname: Hughes fullname: Hughes, Timothy organization: Department of Haematology, SA Pathology and the University of Adelaide, Adelaide, Australia – sequence: 27 givenname: Giuseppe surname: Saglio fullname: Saglio, Giuseppe organization: Department of Clinical and Biological Science, University of Turin, Turin, Italy – sequence: 28 givenname: Andreas surname: Hochhaus fullname: Hochhaus, Andreas organization: Department Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany – sequence: 29 givenname: John M. surname: Goldman fullname: Goldman, John M. organization: Department of Haematology, Imperial College Academic Health Science Centre, Hammersmith Campus, London, United Kingdom; and – sequence: 30 givenname: Paul surname: Metcalfe fullname: Metcalfe, Paul email: ncpc@soton.ac.uk, Paul.Metcalfe@nibsc.hpa.org.uk organization: National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, United Kingdom – sequence: 31 givenname: Nicholas C.P. surname: Cross fullname: Cross, Nicholas C.P. organization: National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20720184$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-139355$$DView record from Swedish Publication Index |
BookMark | eNqFkc1u1DAUhS1URKeFN0DIOzYN-D8JC6TpUNpKI4pG_Cwtj3PTMUrsqe2AaF-eTDNlwYKubNnfObLvd4QOfPCA0EtK3lBasbfrLoSmYISSgqiC1VQJ-gTNqGRVQQgjB2hGyHgj6pIeoqOUfhBCBWfyGTpkpByDlZihu7OUzbpzadODzzi0OG8Aty6mjL-H2DX4AkyXN_gqXhvvbk12weNLnyH6-73p8Dl4yM7iFbQQwVvAn42HDrch4pvB-OzyFBvbTxerYn66xP3q0_w5etqaLsGL_XqMvn48-7K4KJZX55eL-bKwUrBcCKibRppSkspIVralNE3TgmhZzQUoq0Aoxi0Zj6QqpWo5r6uyrrk1RFUE-DE6mXrTL9gOa72Nrjfxtw7G6Q_u21yHeK2HQVNecylH_PWEb2O4GSBl3btkoevGT4Uh6VoKWXNG-aNkRYVQipByJF_tyWHdQ_P3CQ8iRuDdBNgYUorQarufWo7GdZoSvbOu763rnXVNlJ6sj2HxT_ih_5HY-ykG4_B_Oog6Wbfz17gINusmuP8X_AHc48YR |
CitedBy_id | crossref_primary_10_1007_s00277_015_2315_1 crossref_primary_10_1111_j_1365_2141_2012_09203_x crossref_primary_10_1080_21678707_2019_1652598 crossref_primary_10_1038_s41375_023_02048_y crossref_primary_10_47183_mes_2024_244 crossref_primary_10_1016_j_prp_2012_05_008 crossref_primary_10_1016_j_bdq_2017_01_001 crossref_primary_10_5339_connect_2014_24 crossref_primary_10_1586_14737159_2013_835573 crossref_primary_10_1111_ijlh_12600 crossref_primary_10_1586_14737159_2014_927311 crossref_primary_10_1080_10428194_2016_1190974 crossref_primary_10_3390_genes13060948 crossref_primary_10_5858_arpa_2014_0522_LE crossref_primary_10_1016_j_jmoldx_2013_05_010 crossref_primary_10_5858_arpa_2021_0121_OA crossref_primary_10_1038_leu_2012_104 crossref_primary_10_1371_journal_pone_0265278 crossref_primary_10_1007_s40291_020_00485_4 crossref_primary_10_1007_s00103_016_2315_x crossref_primary_10_1016_j_clinbiochem_2014_05_067 crossref_primary_10_1177_2040620716657994 crossref_primary_10_3324_haematol_2019_240739 crossref_primary_10_1016_j_jmoldx_2016_05_008 crossref_primary_10_1097_PAT_0b013e32834a9da8 crossref_primary_10_1128_JCM_02254_14 crossref_primary_10_1177_2374289517708309 crossref_primary_10_1111_bjh_14557 crossref_primary_10_1182_asheducation_2011_1_128 crossref_primary_10_1007_s00277_018_3570_8 crossref_primary_10_1177_20406207241259678 crossref_primary_10_1158_1078_0432_CCR_17_0962 crossref_primary_10_1007_s10147_011_0328_x crossref_primary_10_1016_j_banm_2023_04_001 crossref_primary_10_1515_cclm_2016_0927 crossref_primary_10_1007_s00277_012_1468_4 crossref_primary_10_1111_ijlh_12353 crossref_primary_10_1002_cncr_29053 crossref_primary_10_1111_ejh_13238 crossref_primary_10_1016_j_yamp_2018_07_006 crossref_primary_10_1182_asheducation_2016_1_156 crossref_primary_10_1016_j_leukres_2018_08_021 crossref_primary_10_1373_clinchem_2013_204941 crossref_primary_10_1038_s41375_022_01607_z crossref_primary_10_1182_blood_2011_07_365007 crossref_primary_10_1002_pros_23710 crossref_primary_10_1016_j_mam_2019_10_005 crossref_primary_10_1016_j_clinbiochem_2018_04_015 crossref_primary_10_1038_s41375_024_02275_x crossref_primary_10_1097_HS9_0000000000000496 crossref_primary_10_1111_bjh_17521 crossref_primary_10_1016_j_jmoldx_2013_10_007 crossref_primary_10_1128_JCM_01628_15 crossref_primary_10_1016_j_hoc_2011_09_003 crossref_primary_10_1097_PAT_0b013e32834e4203 crossref_primary_10_5858_arpa_2011_0136_OA crossref_primary_10_1111_ijlh_12919 crossref_primary_10_1016_j_cca_2011_10_022 crossref_primary_10_1016_j_jmoldx_2013_02_004 crossref_primary_10_3892_ol_2017_7720 crossref_primary_10_1038_nrg_2017_44 crossref_primary_10_1016_j_clml_2011_01_001 crossref_primary_10_1016_j_lrr_2023_100373 crossref_primary_10_1111_bjh_13966 crossref_primary_10_1186_s12920_023_01607_7 crossref_primary_10_1038_leu_2015_29 crossref_primary_10_1111_bjh_18046 crossref_primary_10_1016_j_cca_2013_10_016 crossref_primary_10_1182_bloodadvances_2022009379 crossref_primary_10_1373_clinchem_2012_196477 crossref_primary_10_3390_cancers12113287 crossref_primary_10_3109_10428194_2015_1122779 crossref_primary_10_3390_cancers13215470 crossref_primary_10_1186_s40064_016_2258_6 crossref_primary_10_5858_arpa_2013_0754_OA crossref_primary_10_1111_ijlh_12541 crossref_primary_10_1373_clinchem_2012_185132 crossref_primary_10_1007_s11899_011_0082_1 crossref_primary_10_1111_ijlh_14320 crossref_primary_10_1038_leu_2016_197 crossref_primary_10_1016_S0140_6736_13_62120_0 crossref_primary_10_1021_acsomega_2c07885 crossref_primary_10_1002_cam4_801 crossref_primary_10_1515_cclm_2019_1283 crossref_primary_10_1007_s00216_024_05492_6 crossref_primary_10_1038_ejhg_2013_145 crossref_primary_10_1038_leu_2014_217 crossref_primary_10_1038_s41375_022_01612_2 crossref_primary_10_1016_j_exphem_2019_12_002 crossref_primary_10_1016_j_jmoldx_2019_03_002 crossref_primary_10_18632_oncotarget_333 crossref_primary_10_1002_jcla_22612 crossref_primary_10_1007_s11899_013_0192_z crossref_primary_10_1309_LMSE7M60TABHDNEV crossref_primary_10_1038_bcj_2011_10 crossref_primary_10_1016_j_jmoldx_2013_04_007 crossref_primary_10_1080_16078454_2023_2256199 crossref_primary_10_1016_S1773_035X_17_30162_4 crossref_primary_10_3109_10428194_2012_659734 crossref_primary_10_1111_ijlh_12274 crossref_primary_10_3109_10428194_2013_797085 crossref_primary_10_1111_ijlh_12556 crossref_primary_10_1371_journal_pone_0207170 crossref_primary_10_3390_diseases9020035 crossref_primary_10_1016_j_plabm_2021_e00210 crossref_primary_10_1111_j_1365_2141_2011_08603_x crossref_primary_10_1016_j_mayocp_2015_08_010 crossref_primary_10_1634_theoncologist_2015_0337 crossref_primary_10_1002_cncr_32940 crossref_primary_10_1038_leu_2016_90 crossref_primary_10_47429_lmo_2023_13_4_356 crossref_primary_10_1182_blood_2014_03_566323 |
Cites_doi | 10.1182/asheducation-2009.1.371 10.2353/jmoldx.2007.060134 10.1182/blood.V97.6.1560 10.1200/JCO.2009.25.0779 10.1016/j.blre.2005.01.008 10.1182/blood-2006-01-0092 10.1038/leu.2009.168 10.1001/archinte.1994.00420030084008 10.1182/blood-2008-04-150680 10.1016/j.beha.2009.04.001 10.1038/sj.leu.2404983 10.6004/jnccn.2009.0065 10.1056/NEJMoa030513 10.1111/j.1365-2141.1995.tb05257.x 10.1111/j.1365-2141.1992.tb06947.x 10.1016/0140-6736(93)92619-5 10.1038/sj.leu.2404388 10.1046/j.1365-2141.1997.4683272.x 10.3324/haematol.11172 10.1046/j.1365-2141.1999.01749.x 10.1038/sj.leu.2401566 10.1038/sj.leu.2404716 10.1038/sj.leu.2403135 |
ContentType | Journal Article |
Copyright | 2010 American Society of Hematology |
Copyright_xml | – notice: 2010 American Society of Hematology |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TM 8FD FR3 P64 RC3 ADTPV AOWAS DF2 |
DOI | 10.1182/blood-2010-06-291641 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts SwePub SwePub Articles SWEPUB Uppsala universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology Anatomy & Physiology |
EISSN | 1528-0020 |
EndPage | e117 |
ExternalDocumentID | oai_DiVA_org_uu_139355 20720184 10_1182_blood_2010_06_291641 S0006497120310338 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 1CY 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6I. 6J9 9M8 AAEDW AAFTH AAXUO ABOCM ABVKL ACGFO ADBBV AENEX AFFNX AFOSN AHPSJ ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD EX3 F5P FDB FRP GS5 GX1 IH2 K-O KQ8 L7B LSO MJL N4W N9A OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV ZA5 0R~ AALRI AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AGCQF AIGII AITUG AKBMS AKRWK AKYEP AMRAJ CITATION H13 CGR CUY CVF ECM EIF NPM 7X8 7TM 8FD FR3 P64 RC3 .GJ AAQQT AAYWO ADTPV AI. AOWAS C1A DF2 EFKBS J5H MVM OHT VH1 WHG ZGI ZXP |
ID | FETCH-LOGICAL-c542t-4e9dd5a7508a527f75addfe4f2934e6c6e4623c0fe456756f33987993ca0680e3 |
ISSN | 0006-4971 1528-0020 |
IngestDate | Thu Aug 21 07:17:30 EDT 2025 Thu Jul 10 17:31:54 EDT 2025 Fri Jul 11 06:50:15 EDT 2025 Thu Apr 03 06:53:39 EDT 2025 Tue Jul 01 04:18:30 EDT 2025 Thu Apr 24 23:12:47 EDT 2025 Fri Feb 23 02:44:39 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Language | English |
License | This article is made available under the Elsevier license. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c542t-4e9dd5a7508a527f75addfe4f2934e6c6e4623c0fe456756f33987993ca0680e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://dx.doi.org/10.1182/blood-2010-06-291641 |
PMID | 20720184 |
PQID | 814466007 |
PQPubID | 23479 |
ParticipantIDs | swepub_primary_oai_DiVA_org_uu_139355 proquest_miscellaneous_954593213 proquest_miscellaneous_814466007 pubmed_primary_20720184 crossref_citationtrail_10_1182_blood_2010_06_291641 crossref_primary_10_1182_blood_2010_06_291641 elsevier_sciencedirect_doi_10_1182_blood_2010_06_291641 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-11-25 |
PublicationDateYYYYMMDD | 2010-11-25 |
PublicationDate_xml | – month: 11 year: 2010 text: 2010-11-25 day: 25 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Blood |
PublicationTitleAlternate | Blood |
PublicationYear | 2010 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Baccarani, Cortes, Pane (bib2) 2009; 27 Ottmann, Pfeifer (bib3) 2009 Lion, Henn, Gaiger, Kalhs, Gadner (bib25) 1993; 341 O'Brien, Berman, Borghaei (bib1) 2009; 7 Raanani, Dazzi, Sohal (bib22) 1997; 99 Cross (bib5) 2009; 22 World Health Organization. (bib14) 2006; 932 Müller, Erben, Saglio (bib26) 2008; 22 Branford, Cross, Hochhaus (bib10) 2006; 20 Branford, Fletcher, Cross (bib11) 2008; 112 Zhang, Grenier, Nwachukwu, Wei, Lipton, Kamel-Reid (bib6) 2007; 9 Müller, Saglio, Lin (bib7) 2007; 92 Hirsh, Poller (bib12) 1994; 154 Gabert, Beillard, van der Velden (bib4) 2003; 17 Hughes, Branford (bib16) 2006; 20 White HE, Cross NCP, Freeze dried cell lines as reference materials for standardisation of BCR-ABL RQPCR methods: report of a field trial evaluation., Accessed June 23, 2010, 1-53. 2008. www.ngrl.org.uk/Wessex/downloads/pdf/NGRLW_NIBSC_BCR_ABL_1.0.pdf. Cross, Melo, Feng, Goldman (bib18) 1994; 8 Malinge, Mahon, Delfau (bib23) 1992; 82 Hughes, Deininger, Hochhaus (bib8) 2006; 108 Hochhaus, Lin, Reiter (bib21) 1995; 91 Olavarria, Kanfer, Szydlo (bib24) 2001; 97 Branford, Hughes, Rudzki (bib19) 1999; 107 Saldanha, Silvy, Beaufils (bib15) 2007; 21 Müller, Cross, Erben (bib13) 2009; 23 Hughes, Kaeda, Branford (bib9) 2003; 349 Emig, Saussele, Wittor (bib20) 1999; 13 Hochhaus (2019111822375024500_B21) 1995; 91 Ottmann (2019111822375024500_B3) 2009 Müller (2019111822375024500_B26) 2008; 22 World Health Organization. (2019111822375024500_B14) 2006; 932 Olavarria (2019111822375024500_B24) 2001; 97 Hughes (2019111822375024500_B16) 2006; 20 Lion (2019111822375024500_B25) 1993; 341 Zhang (2019111822375024500_B6) 2007; 9 O'Brien (2019111822375024500_B1) 2009; 7 Gabert (2019111822375024500_B4) 2003; 17 Müller (2019111822375024500_B13) 2009; 23 Branford (2019111822375024500_B11) 2008; 112 Raanani (2019111822375024500_B22) 1997; 99 Baccarani (2019111822375024500_B2) 2009; 27 Müller (2019111822375024500_B7) 2007; 92 2019111822375024500_B17 Cross (2019111822375024500_B5) 2009; 22 Hughes (2019111822375024500_B8) 2006; 108 Hughes (2019111822375024500_B9) 2003; 349 Branford (2019111822375024500_B10) 2006; 20 Malinge (2019111822375024500_B23) 1992; 82 Saldanha (2019111822375024500_B15) 2007; 21 Emig (2019111822375024500_B20) 1999; 13 Cross (2019111822375024500_B18) 1994; 8 Hirsh (2019111822375024500_B12) 1994; 154 Branford (2019111822375024500_B19) 1999; 107 |
References_xml | – volume: 97 start-page: 1560 year: 2001 end-page: 1565 ident: bib24 article-title: Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. publication-title: Blood – volume: 20 start-page: 1925 year: 2006 end-page: 1930 ident: bib10 article-title: Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. publication-title: Leukemia – volume: 341 start-page: 275 year: 1993 end-page: 276 ident: bib25 article-title: Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. publication-title: Lancet – volume: 21 start-page: 1481 year: 2007 end-page: 1487 ident: bib15 article-title: Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements. publication-title: Leukemia – volume: 13 start-page: 1825 year: 1999 end-page: 1832 ident: bib20 article-title: Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. publication-title: Leukemia – volume: 8 start-page: 186 year: 1994 end-page: 189 ident: bib18 article-title: An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. publication-title: Leukemia – volume: 91 start-page: 126 year: 1995 end-page: 131 ident: bib21 article-title: Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha. publication-title: Br J Haematol – volume: 349 start-page: 1423 year: 2003 end-page: 1432 ident: bib9 article-title: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. publication-title: N Engl J Med – volume: 9 start-page: 421 year: 2007 end-page: 430 ident: bib6 article-title: Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations. publication-title: J Mol Diagn – volume: 7 start-page: 984 year: 2009 end-page: 1023 ident: bib1 article-title: NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. publication-title: J Natl Compr Canc Netw – volume: 20 start-page: 29 year: 2006 end-page: 41 ident: bib16 article-title: Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia. publication-title: Blood Rev – start-page: 371 year: 2009 end-page: 381 ident: bib3 article-title: Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). publication-title: Hematology Am Soc Hematol Educ Program – volume: 22 start-page: 355 year: 2009 end-page: 365 ident: bib5 article-title: Standardisation of molecular monitoring for chronic myeloid leukaemia. publication-title: Best Pract Res Clin Haematol – volume: 99 start-page: 945 year: 1997 end-page: 950 ident: bib22 article-title: The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. publication-title: Br J Haematol – volume: 22 start-page: 96 year: 2008 end-page: 102 ident: bib26 article-title: Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. publication-title: Leukemia – volume: 932 start-page: 1 year: 2006 end-page: 137 ident: bib14 article-title: WHO Expert Committee on Biological Standardization. publication-title: World Health Organization Technical Report Series – volume: 154 start-page: 282 year: 1994 end-page: 288 ident: bib12 article-title: The international normalized ratio. A guide to understanding and correcting its problems. publication-title: Arch Intern Med – volume: 108 start-page: 28 year: 2006 end-page: 37 ident: bib8 article-title: Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. publication-title: Blood – volume: 27 start-page: 6041 year: 2009 end-page: 6051 ident: bib2 article-title: Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. publication-title: J Clin Oncol – volume: 82 start-page: 701 year: 1992 end-page: 707 ident: bib23 article-title: Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy. publication-title: Br J Haematol – volume: 107 start-page: 587 year: 1999 end-page: 599 ident: bib19 article-title: Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. publication-title: Br J Haematol – volume: 17 start-page: 2318 year: 2003 end-page: 2357 ident: bib4 article-title: Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. publication-title: Leukemia – volume: 92 start-page: 970 year: 2007 end-page: 973 ident: bib7 article-title: An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. publication-title: Haematologica – reference: White HE, Cross NCP, Freeze dried cell lines as reference materials for standardisation of BCR-ABL RQPCR methods: report of a field trial evaluation., Accessed June 23, 2010, 1-53. 2008. www.ngrl.org.uk/Wessex/downloads/pdf/NGRLW_NIBSC_BCR_ABL_1.0.pdf. – volume: 23 start-page: 1957 year: 2009 end-page: 1963 ident: bib13 article-title: Harmonization of molecular monitoring of CML therapy in Europe. publication-title: Leukemia – volume: 112 start-page: 3330 year: 2008 end-page: 3338 ident: bib11 article-title: Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. publication-title: Blood – start-page: 371 year: 2009 ident: 2019111822375024500_B3 article-title: Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). publication-title: Hematology Am Soc Hematol Educ Program doi: 10.1182/asheducation-2009.1.371 – volume: 9 start-page: 421 issue: 4 year: 2007 ident: 2019111822375024500_B6 article-title: Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations. publication-title: J Mol Diagn doi: 10.2353/jmoldx.2007.060134 – volume: 97 start-page: 1560 issue: 6 year: 2001 ident: 2019111822375024500_B24 article-title: Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. publication-title: Blood doi: 10.1182/blood.V97.6.1560 – volume: 932 start-page: 1 issue: v-vi year: 2006 ident: 2019111822375024500_B14 article-title: WHO Expert Committee on Biological Standardization. publication-title: World Health Organization Technical Report Series – volume: 27 start-page: 6041 issue: 35 year: 2009 ident: 2019111822375024500_B2 article-title: Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. publication-title: J Clin Oncol doi: 10.1200/JCO.2009.25.0779 – volume: 20 start-page: 29 issue: 1 year: 2006 ident: 2019111822375024500_B16 article-title: Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia. publication-title: Blood Rev doi: 10.1016/j.blre.2005.01.008 – volume: 108 start-page: 28 issue: 1 year: 2006 ident: 2019111822375024500_B8 article-title: Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. publication-title: Blood doi: 10.1182/blood-2006-01-0092 – volume: 23 start-page: 1957 issue: 11 year: 2009 ident: 2019111822375024500_B13 article-title: Harmonization of molecular monitoring of CML therapy in Europe. publication-title: Leukemia doi: 10.1038/leu.2009.168 – volume: 154 start-page: 282 issue: 3 year: 1994 ident: 2019111822375024500_B12 article-title: The international normalized ratio. A guide to understanding and correcting its problems. publication-title: Arch Intern Med doi: 10.1001/archinte.1994.00420030084008 – volume: 112 start-page: 3330 issue: 8 year: 2008 ident: 2019111822375024500_B11 article-title: Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. publication-title: Blood doi: 10.1182/blood-2008-04-150680 – volume: 22 start-page: 355 issue: 3 year: 2009 ident: 2019111822375024500_B5 article-title: Standardisation of molecular monitoring for chronic myeloid leukaemia. publication-title: Best Pract Res Clin Haematol doi: 10.1016/j.beha.2009.04.001 – volume: 8 start-page: 186 issue: 1 year: 1994 ident: 2019111822375024500_B18 article-title: An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. publication-title: Leukemia – volume: 22 start-page: 96 issue: 1 year: 2008 ident: 2019111822375024500_B26 article-title: Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. publication-title: Leukemia doi: 10.1038/sj.leu.2404983 – volume: 7 start-page: 984 issue: 9 year: 2009 ident: 2019111822375024500_B1 article-title: NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. publication-title: J Natl Compr Canc Netw doi: 10.6004/jnccn.2009.0065 – volume: 349 start-page: 1423 issue: 15 year: 2003 ident: 2019111822375024500_B9 article-title: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. publication-title: N Engl J Med doi: 10.1056/NEJMoa030513 – ident: 2019111822375024500_B17 – volume: 91 start-page: 126 issue: 1 year: 1995 ident: 2019111822375024500_B21 article-title: Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha. publication-title: Br J Haematol doi: 10.1111/j.1365-2141.1995.tb05257.x – volume: 82 start-page: 701 issue: 4 year: 1992 ident: 2019111822375024500_B23 article-title: Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy. publication-title: Br J Haematol doi: 10.1111/j.1365-2141.1992.tb06947.x – volume: 341 start-page: 275 issue: 8840 year: 1993 ident: 2019111822375024500_B25 article-title: Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. publication-title: Lancet doi: 10.1016/0140-6736(93)92619-5 – volume: 20 start-page: 1925 issue: 11 year: 2006 ident: 2019111822375024500_B10 article-title: Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. publication-title: Leukemia doi: 10.1038/sj.leu.2404388 – volume: 99 start-page: 945 issue: 4 year: 1997 ident: 2019111822375024500_B22 article-title: The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. publication-title: Br J Haematol doi: 10.1046/j.1365-2141.1997.4683272.x – volume: 92 start-page: 970 issue: 7 year: 2007 ident: 2019111822375024500_B7 article-title: An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. publication-title: Haematologica doi: 10.3324/haematol.11172 – volume: 107 start-page: 587 year: 1999 ident: 2019111822375024500_B19 article-title: Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. publication-title: Br J Haematol doi: 10.1046/j.1365-2141.1999.01749.x – volume: 13 start-page: 1825 issue: 11 year: 1999 ident: 2019111822375024500_B20 article-title: Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. publication-title: Leukemia doi: 10.1038/sj.leu.2401566 – volume: 21 start-page: 1481 issue: 7 year: 2007 ident: 2019111822375024500_B15 article-title: Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements. publication-title: Leukemia doi: 10.1038/sj.leu.2404716 – volume: 17 start-page: 2318 issue: 12 year: 2003 ident: 2019111822375024500_B4 article-title: Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. publication-title: Leukemia doi: 10.1038/sj.leu.2403135 |
SSID | ssj0014325 |
Score | 2.4027016 |
Snippet | Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia... |
SourceID | swepub proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e111 |
SubjectTerms | Abl protein Acute lymphatic leukemia BCR protein Blood Cell Line Chromosome translocations Chronic myeloid leukemia Fusion protein Fusion Proteins, bcr-abl - genetics Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics MEDICIN MEDICINE mRNA Polymerase chain reaction Quantitation Reference Standards Reverse Transcriptase Polymerase Chain Reaction - methods Reverse Transcriptase Polymerase Chain Reaction - standards RNA, Messenger - genetics Standardization World Health Organization |
Title | Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA |
URI | https://dx.doi.org/10.1182/blood-2010-06-291641 https://www.ncbi.nlm.nih.gov/pubmed/20720184 https://www.proquest.com/docview/814466007 https://www.proquest.com/docview/954593213 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-139355 |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEJcXBB2XcpMfgBeUkjr3x7QMpsEmqDa0NytJnanbmkwjQQL-POfYJ1nTrRrwEkWJ40T5vjjfsc-FsVcicwIxsx1LgVq33ChTVqrCzHKVbydpmihb6Wyfe_72gbtz6B32ej-WvJbqKh1mv66MK_kfVOEY4IpRsv-AbNspHIB9wBe2gDBs_wrjLZB2ehapWdFHFZnPQdCRkwwFGS0HXK7MAWLa6Uo70zcJZ78khdJBjRhwWVSUwxt7H0-mVjz-_HYx3Ys7i8GnVHF-uFxxT__QLgIddkHUHldgS9cnqx6J0_kRJfjseAt_TFIKKNpRxGGankBXj5FlQpmHioZUzIFtC7sz5poASyKXiUymIVTR6Ht5bA8xV6zx5zdr-L4lQN26neaA0NlC4y3sAJqZAnQrObWbUzfYTQHmBY6Pn75erD65jvAozBJu-u6qW2ISaepknaK5bLGspKPVEmb_PrtHtgePDZEesJ4q-mwzBi6Ui5_8DdfewHqZpc9ujZu9O5OmJmCf3d4lV4xN9rtDPl7mHMjHNfm4Jh835OPL5OMd8nEiH2_JxzX5OJCPL5MPeyfycSTfQ3bwYWt_sm1RJQ8r81xRwZcfzWZeAuo0TDwR5IEHv9VcuTmITRgVMl-5IMMzGw55YMH6ueNEYQDSOUuwNoxyHrGNoizUE8Yxo2OOBWLyPIQtNEsiEWIVgdCdJY4_YE6DhszoKbHayqnU5m4opIZTIpzS9qWBc8Cs9qozk-blmvZBA7QkqWokqAS2XnMlb3ghATxcnoM3W9bfZYhTM1guYn2TCOwdMLhGzoA9NpRqn7Zh44C9Nhxrz2AC-ffzb7Esz49kXcsRRuN7T9f28IzdbT5ke_ScbVTntXoByrtKX-rP5A8XHtWU |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Establishment+of+the+first+World+Health+Organization+International+Genetic+Reference+Panel+for+quantitation+of+BCR-ABL+mRNA&rft.jtitle=Blood&rft.au=White%2C+Helen+E&rft.au=Matejtschuk%2C+Paul&rft.au=Rigsby%2C+Peter&rft.au=Gabert%2C+Jean&rft.date=2010-11-25&rft.eissn=1528-0020&rft.volume=116&rft.issue=22&rft.spage=e111&rft_id=info:doi/10.1182%2Fblood-2010-06-291641&rft_id=info%3Apmid%2F20720184&rft.externalDocID=20720184 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon |